Stay updated on Acalabrutinib in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added “Ovarian cancer” related topics under MedlinePlus/MedlinePlus Genetics sections.
    Difference
    0.2%
    Check dated 2026-04-23T15:22:47.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:31.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:28:43.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The header revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:37.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Related topic links for ovarian cancer and MedlinePlus Genetics were added to the page to improve cross-referencing for readers.
    Difference
    0.2%
    Check dated 2026-03-04T14:22:02.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Removes mentions of 'Ovarian cancer' and related topics such as 'MedlinePlus Genetics', reducing disease-specific context and linked informational resources on the study page.
    Difference
    0.2%
    Check dated 2026-02-25T09:27:36.000Z thumbnail image

Stay in the know with updates to Acalabrutinib in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib in Ovarian Cancer Clinical Trial page.